← All stocks

Minerva Neurosciences, Inc.

NERV Net selling

CIK 0001598646 #3840 in the set updated 22 Sep 2026

Bought (120 mo)

$819.95K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$7.59M

$0.00 on a plan · $1.86M straight out of an exercise

Sold at will

$5.72M

39 of 54 sales

Net

−$6.77M

−$4.90M against sales at will

By person

16 insiders · 75 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Index Venture Associates III Ltd entity

10% owner

—

$4.84M (17)

−$4.84M

8,590,095

$32.30M

−6.4%

Reilly Joseph H.

SVP & Chief Operating Officer

—

$635.84K (8) scheduled

−$635.84K

31,747

$119.37K

+281.0%

Ahlholm Frederick W

SVP, CFO and Secretary

—

$617.67K (9) scheduled

−$617.67K

17,518

$65.87K

+1,341%

Luthringer Remy

CEO

—

$535.69K (8) scheduled

−$535.69K

995,598

$3.74M

+14.6%

Race Geoff

President

—

$457.57K (7)

−$457.57K

51,324

$192.98K

+136.4%

Beer Marc D

Director

$405.75K (2)

—

+$405.75K

50,000

$188.00K

—

Levine Mark S.

SVP,General Counsel & Sec.

—

$402.50K (2) scheduled

−$402.50K

$0.00

—

DOYLE WILLIAM F

Director

$222.96K (11)

—

+$222.96K

26,111

$98.18K

—

VAN HEEK G JAN

Director

$74.49K (2)

—

+$74.49K

20,333

$76.45K

+510.1%

HASLER HANS PETER

Director

$56.00K (1)

—

+$56.00K

10,000

$37.60K

—

Russell Richard E.

President

—

$47.91K (2)

−$47.91K

33,770

$126.98K

—

Kupfer David

Director

$55.50K (1)

$48.96K (1)

+$6.54K

191,488

$719.99K

−19.2%

HILLEMAN JERYL L

Director

$5.25K (1)

—

+$5.25K

1,000

$3.76K

—

Ollier Michele

Director

—

4,690,906

$17.64M

+4.5%

De Rubertis Francesco

Director

—

4,690,906

$17.64M

+4.5%

JOHNSON & JOHNSON

10% owner

—

$0.00

−100.0%

No percentages here. This company's share count has moved by a factor of 6.8 over the window, from 6,993,406 to 47,747,559 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 183

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 11

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 15

Sales at will 39

Transactions with no price 0

Shares from compensation/vesting 5,029,577

Sales filed before the plan box existed 35

History held since 14 Dec 2016